Walgreens announces purchase of Rite Aid in $17.2 billion deal. Read More »

A recent study by the Drug Channels Institute, a leading management educator for and about the pharmaceutical industry, analyzed the highly dynamic prescription drug distribution industry. Read More »

Cigna said Monday it recently launched a collaborative care initiative, Cigna Collaborative Care, with the Elliot Physician Network to improve patient access to health care, increase care coordination and achieve improved health, affordability and patient experience in Southern New Hampshire. Read More »

A study conducted by the National Community Pharmacists Association (NCPA) found that independent community pharmacists are able to improve patient health by networking together across diverse practice settings, an article in Pharmacy Times said on Monday. Read More »

President Barack Obama announced a plan Wednesday to combat the nation's drug crisis by boosting training for care providers who prescribe opioids and improving access to treatment facilities for people with addiction. “The drug epidemic this country is facing can only be defeated through collaboration and support from government officials as well as care providers and technology leaders,” Surescripts CEO Tom Skelton said. Read More »

The American Society of Health-System Pharmacists (ASHP) said Thursday it will hold its first virtual House of Delegates session Nov. 13-20 to give delegates the chance to take early action on ASHP policy recommendations through online discussion and voting. Read More »

During Capitol Hill Health Fair on Wednesday, APhA will urge lawmakers to back pharmacy bill Read More »

The U.S. Food and Drug Administration (FDA) recently approved Dyanavel XR (amphetamine), extended-release oral suspension, CII, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children six years and older, according to an announcement from Tris Pharma Inc. on Tuesday. Read More »

The ‘authorized generic’ version of a drug is an important product consideration for patients, an executive at Sanofi US advised. Read More »

The U.S. Food and Drug Administration (FDA) on Tuesday approved Coagadex for hereditary Factor X (10) deficiency. Read More »

American Society of Health-System Pharmacists (ASHP) on Wednesday announced that there are now 2,000 residency programs across the country currently undergoing the ASHP accreditation process. Read More »

NCPA recommended improvements to benefit patients and taxpayers at a recent House Energy and Commerce Subcommittee on Health hearing about medication therapy management (MTM) in the Medicare Part D program. Read More »

LEO Pharma recently announced that Enstilar Foam for plaque psoriasis has been approved by the U.S. Food and Drug Administration. Read More »

Aetna and Rush Health on Oct. 15 announced a collaboration to launch Aetna Whole Health Chicago, a commercial healthcare product in Illinois that will give members access to coordinated care. Read More »

National Community Pharmacists Association (NCPA) data released Oct.13 indicates that despite decreasing prescription reimbursements and the narrowing of pharmacy networks, the nation's independent community pharmacies continue to beat the odds and diversify their revenues. Read More »

Aetna said its shareholders voted Monday to approve the issuance of Aetna common shares to Humana stockholders in connection with Aetna’s proposed acquisition of Humana. Read More »

Health Mart pharmacies said Monday it is gearing up for its third series of town hall events. This series, titled “Get in Sync: Medication Synchronization,” is aimed at getting pharmacists to think about adopting appointment-based models with medication synchronization to take them from reactive prescription filling to proactive and patient-centric filling. Read More »

The American Society of Health-System Pharmacists (ASHP) said Friday it is disappointed with the recent decision of the U.S District Court for the District of Columbia that will omit all drugs with an “orphan” designation from the 340B Drug Pricing Program for rural and cancer hospitals. Read More »

The 28th annual McKesson Health Solutions Conference  (MHSC) kicked off Monday at the Aria Resort and Casino in Las Vegas. More than 300 health care professionals from leading payers and providers will engage in networking, learning and focusing on a better future for health care at the conference that runs through Thursday. Read More »

AstraZeneca said the U.S. Food and Drug Administration (FDA) issued a complete response letter (CRL) about the new drug application (NDA) for the investigational fixed-dose combination of saxagliptin and dapagliflozin. The fixed-dose combination of saxagliptin and dapagliflozi is intended for the treatment of adult patients with Type 2 diabetes.  The CRL said more clinical data is required to support NDA. Read More »